In vivo effects of adriamycin or N-trifluoroacetyladriamycin-14-valerate on a mouse lymphoma.
D000818:Animals; D001402:B-Lymphocytes; D002470:Cell Survival; D004260:DNA Repair / Q000187:drug effects; D004273:DNA, Neoplasm / Q000032:analysis; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005434:Flow Cytometry; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D012334:RNA, Neoplasm / Q000032:analysis; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D014750:Vincristine / Q000494:pharmacology
D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; C016163:valrubicin; D014750:Vincristine; D004317:Doxorubicin